Publication | Closed Access

Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations

MedicineGrowth Factor ReceptorReceptor Tyrosine KinasePathologyBronchial NeoplasmTyrosine Kinase InhibitorsCancer GeneticsEgfr MutationsOncologyRadiation OncologyLung Cancer